Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Atlantis Dawn Russ"'
Autor:
Helena E. Richardson, Kathryn M. Guthridge, Linda M. Parsons, Atlantis Dawn Russ, Scott G. Daniel, Daniela C. Zarnescu, Patricia S. Estes, Ammad I. Raina, Joyce A. Schroeder
Publikováno v:
Biology Open, Vol 7, Iss 1 (2018)
Biology Open
Biology Open
Drosophila lethal giant larvae (lgl) encodes a conserved tumor suppressor with established roles in cell polarity, asymmetric division, and proliferation control. Lgl's human orthologs, HUGL1 and HUGL2, are altered in human cancers, however, its mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c90ab8ebb55a0268b540c1d9796295
Autor:
Atlantis Dawn Russ, Ahmad Iftikhar, Kevin Gee, Sabina Saeed, Mirza Saqib Baig, Steffan T. Nawrocki, Ali McBride, Jason Valent, Nadia Carenina Nunes Cavalcante Parr, Jennifer S. Carew, Christy J. Samaras, Faryal Razzaq, Hussam Al-Kateb, Muhammad Abu Zar, Faiz Anwer
Publikováno v:
Clin Lymphoma Myeloma Leuk
Multiple myeloma (MM) is genetically complex disease. Identification of mutations and aberrant signaling pathways that contribute to the progression of MM and drug resistance has potential to lead to specific targets and personalized treatment. Aberr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3923fca21c63aa492ba283441ebea774
https://doi.org/10.1016/j.clml.2019.03.017
https://doi.org/10.1016/j.clml.2019.03.017
Autor:
Zeeshan Baig, Seren Durer, Muhammad Junaid Tariq, Muhammad Usman, Ali Younas Khan, Muhammad Asad Fraz, Nadia Carenina Nunes Cavalcante Parr, Saad Ullah Malik, Atlantis Dawn Russ, Ceren Durer, Faiz Anwer, Warda Faridi, Fnu Sagar, Awais Ijaz, Ali McBride, Zeeshan Ali
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:94-99
Investigators are using checkpoint inhibitors (CPIs) to treat aggressive hematologic malignancies in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in some patients with relapsed disease after allo-HSCT. CTLA-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26247d7e5e7c8c54edf58fa00bab36f
https://doi.org/10.1016/j.bbmt.2018.08.028
https://doi.org/10.1016/j.bbmt.2018.08.028
Autor:
Atlantis Dawn Russ, Muhammad Umar Khalid, Faiz Anwer, Daniel O. Persky, Bushra Rahman, Irbaz Bin Riaz, William R. Montfort, Jennifer S. Carew, Anh Hua, Steffan T. Nawrocki
Publikováno v:
Blood Reviews. 32:480-489
Hematological malignancies express high levels of CD47 as a mechanism of immune evasion. CD47-SIRPα triggers a cascade of events that inhibit phagocytosis. Preclinical research supports several models of antibody-mediated blockade of CD47-SIRPα res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9a9e2f4452a57b0e39587c943171c1
https://doi.org/10.1016/j.blre.2018.04.005
https://doi.org/10.1016/j.blre.2018.04.005
Autor:
Atlantis Dawn Russ, Sabrina Maisel, Erin Greenwood, David Ebertz, Joyce A. Schroeder, Ritu Pandey
Publikováno v:
Oncotarget
// Erin Greenwood 1 , Sabrina Maisel 2,5,* , David Ebertz 1,* , Atlantis Russ 1,4 , Ritu Pandey 2,6 and Joyce Schroeder 1,2,3,4,5 1 Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 2 Arizona Cancer Center, Universi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c20c5a69ac61bdfaea7849596d58fa
https://doi.org/10.18632/oncotarget.11320
https://doi.org/10.18632/oncotarget.11320
Autor:
Azka Latif, Midhat Lakhani, Anne Hubben, Atlantis Dawn Russ, Udhayvir Singh Grewal, Fazal Raziq, Rajshekhar Chakraborty, Faiz Anwer, Rujul H Parikh, Vikas Kapoor, Afia Ashraf, Ammara Majeed
Publikováno v:
Journal of Clinical Oncology. 37:e19537-e19537
e19537 Background: To improve outcomes, multiple agents with varied mechanisms of action targeting different multiple myeloma (MM) clones are needed. Methods: Systematic review of ongoing phase I-III clinical trials in newly diagnosed multiple myelom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0847401a6c58fbfba3809a931d2217b
https://doi.org/10.1200/jco.2019.37.15_suppl.e19537
https://doi.org/10.1200/jco.2019.37.15_suppl.e19537
Autor:
Ahmad Iftikhar, Afia Ashraf, Faiz Anwer, Nadia Carenina Nunes Cavalcante Parr, Atlantis Dawn Russ, Ahsan Wahab, Abhijeet Kumar, Prem Kumar Thirunagari, Aida Siyahian, Ammara Majeed
Publikováno v:
Journal of Clinical Oncology. 37:e19043-e19043
e19043 Background: Mantle Cell Lymphoma (MCL) is generally treated with rituximab (R) in combination with other drugs. However, treatment for relapsed or refractory (RR) MCL is challenging. For Ibrutinib (Ibr), we aim to determine the efficacy in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adba04280edb463499b45e69640d7511
https://doi.org/10.1200/jco.2019.37.15_suppl.e19043
https://doi.org/10.1200/jco.2019.37.15_suppl.e19043
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47734 (2012)
PLoS ONE
PLoS ONE
Loss of epithelial polarity is described as a hallmark of epithelial cancer. To determine the role of Hugl1 and Hugl2 expression in the breast, we investigated their localization in human mammary duct tissue and the effects of expression modulation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0befa414767b680ee2913e5fb20ff99
http://europepmc.org/articles/PMC3479147?pdf=render
http://europepmc.org/articles/PMC3479147?pdf=render